Naturally circulating dendritic cells to vaccinate cancer patients

被引：32

作者：

Bol, Kalijn F. ^{[1
,2
]}

Tel, Jurjen ^{[1
]}

de Vries, I. Jolanda M. ^{[1
,2
]}

Figdor, Carl G. ^{[1
]}

机构：

[1] Radboud Univ Nijmegen, Med Ctr, Nijmegen Ctr Mol Life Sci, Dept Tumor Immunol, NL-6525 ED Nijmegen, Netherlands

[2] Radboud Univ Nijmegen, Med Ctr, Dept Med Oncol, NL-6525 ED Nijmegen, Netherlands

来源：

ONCOIMMUNOLOGY | 2013年 / 2卷 / 03期

关键词：

cancer immunotherapy; dendritic-cell targeting; dendritic-cell vaccination; myeloid dendritic cells; plasmacytoid dendritic cells;

D O I：

10.4161/onci.23431

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 [肿瘤学];

摘要：

Dendritic cell-based immunotherapy is a promising strategy against cancer that appears to be feasible, safe and to induce potent tumor-specific immune responses. The use of naturally circulating dendritic cells (DCs), rather than cultured monocyte-derived DCs, might constitute the next logical step to translate anticancer immune responses into long-lasting clinical benefits.

引用

页数：3

共 9 条

[1]

Targeting CD4+ T-Helper Cells Improves the Induction of Antitumor Responses in Dendritic Cell-Based Vaccination [J].

Aarntzen, Erik H. J. G. ;

De Vries, I. Jolanda M. ;

Lesterhuis, W. Joost ;

Schuurhuis, Danita ;

Jacobs, Joannes F. M. ;

Bol, Kalijn ;

Schreibelt, Gerty ;

Mus, Roel ;

De Wilt, Johannes H. W. ;

Haanen, John B. A. G. ;

Schadendorf, Dirk ;

Croockewit, Alexandra ;

Blokx, Willeke A. M. ;

Van Rossum, Michelle M. ;

Kwok, William W. ;

Adema, Gosse J. ;

Punt, Cornelis J. A. ;

Figdor, Carl G. .

CANCER RESEARCH, 2013, 73 (01) :19-29

[2]

How many dendritic cells are required to initiate a T-cell response? [J].

Celli, Susanna ;

Day, Mark ;

Mueller, Andreas J. ;

Molina-Paris, Carmen ;

Lythe, Grant ;

Bousso, Philippe .

BLOOD, 2012, 120 (19) :3945-3948

[3]

Prophylactic vaccines mimic synthetic CpG oligonucleotides in their ability to modulate immune responses [J].

de Vries, I. Jolanda M. ;

Tel, Jurjen ;

Benitez-Ribas, Daniel ;

Torensma, Ruurd ;

Figdor, Carl G. .

MOLECULAR IMMUNOLOGY, 2011, 48 (6-7) :810-817

[4]

Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity [J].

Liu, YJ .

CELL, 2001, 106 (03) :259-262

[5]

Cancer immunotherapy via dendritic cells [J].

Palucka, Karolina ;

Banchereau, Jacques .

NATURE REVIEWS CANCER, 2012, 12 (04) :265-277

[6]

Targeted delivery of TLR ligands to human and mouse dendritic cells strongly enhances adjuvanticity [J].

Tacken, Paul J. ;

Zeelenberg, Ingrid S. ;

Cruz, Luis J. ;

van Hout-Kuijer, Maaike A. ;

van de Glind, Gerline ;

Fokkink, Remco G. ;

Lambeck, Annechien J. A. ;

Figdor, Carl G. .

BLOOD, 2011, 118 (26) :6836-6844

[7]

Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines [J].

Tacken, Paul J. ;

Figdor, Carl G. .

SEMINARS IN IMMUNOLOGY, 2011, 23 (01) :12-20

[8]

Tel J, 2012, BLOOD IN PRESS, DOI DOI 10.1182/BL00D-2012-06-435644

[9]

Human plasmacytoid dendritic cells are equipped with antigen-presenting and tumoricidal capacities [J].

Tel, Jurjen ;

Smits, Evelien L. ;

Anguille, Sebastien ;

Joshi, Rubin N. ;

Figdor, Carl G. ;

de Vries, I. Jolanda M. .

BLOOD, 2012, 120 (19) :3936-3944

← 1 →